MedPath

A clinical study to compare the treatment response in asthmatic children between 5 to 15 years of age via Metered dose inhaler with spacer Vs Nebuliser

Not Applicable
Conditions
Health Condition 1: J459- Other and unspecified asthma
Registration Number
CTRI/2020/03/023829
Lead Sponsor
Dr Arunprasath P
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Mild to Moderate Asthmatic children aged between 5 to 15 years,as per GINA Guidelines 2018 updates

Exclusion Criteria

Severe asthmatic children aged between 5 to 15 years ,as per GINA guidelines 2018 updates

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
After treatment with Levosalbutamol via metered dose inhaler with spacer Vs Nebuliser,Reassess the children after 1 hour based on Pulmonary Index Score(Respiratory Rate,Wheezing,Inspiratory And Expiratory Ratio,Use of Accessory Muscle,Oxygen saturation)Timepoint: 1 Years
Secondary Outcome Measures
NameTimeMethod
During Reassessment after 1 hour of treatment,Look for whether the child discharged as outpatient,admitted in ward or admitted at paediatric ICUTimepoint: variable
© Copyright 2025. All Rights Reserved by MedPath